Stock 4564 ONCOTHERAPY SCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases OncoTherapy Science, Inc.

Equities

4564

JP3202150003

Delayed Japan Exchange
Other stock markets
 07:00:00 22/05/2024 BST 		5-day change 1st Jan Change
15 JPY -6.25% Intraday chart for OncoTherapy Science, Inc. -6.25% -34.78%
04-29 Poland's Tusk calls prosecutor over potential Orlen scandal RE
04-22 OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Triple Negative Breast Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
AQ
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 | Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.
AQ
OncoTherapy Science : Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer
PU
OncoTherapy Science : Japanese bio-venture starts development of COVID-19 peptide vaccine
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4564 Stock
  4. News OncoTherapy Science, Inc.
  5. Press Releases